The Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Southern Medical Association designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medium/Method of Participation
This is a 0.5-credit CME activity. To receive credit, read the introductory CME material, complete all of the modules, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 22, 2020
Expiration Date: October 21, 2021
Estimated Time to Complete This Activity: 30 minutes
The Southern Medical Association and Med-IQ require any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. The Southern Medical Association and Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. The Southern Medical Association and Med-IQ also require faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Lisa Fitzpatrick, MD, MPH, MPA, has indicated no real or apparent conflicts.
David J. Malebranche, MD, MPH
Consulting fees/advisory boards: Gilead Sciences, Inc.
Fees received for promotional/non-CME activities: Gilead Sciences, Inc.
The writer, peer reviewers, and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, the Southern Medical Association and Med-IQ have a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. The Southern Medical Association is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
The Southern Medical Association or Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email email@example.com.
The following material has been developed to accompany this activity:
Note: This material is not accredited for CME and, therefore, does not offer any CME/CE credit.
Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available at the "Continue" button below.
Over the last 30 years, ART regimens have shifted from regimens with high pill burdens, treatment-limiting toxicities, and incomplete virologic suppression to simplified regimens that lessen pill burden, reduce toxicity, and maximize viral suppression.
Module 1: Goals of Antiretroviral Therapy
Module 2: Initiating Antiretroviral Therapy
Module 3: Available First-Line Regimens
Module 4: Common Adverse Effects of Antiretroviral Therapy
Module 5: Supporting Adherence at Follow-Up Visits
Click "Continue" to proceed through this activity and receive credit, or select a specific module from the menu on the left. To receive credit and a certificate, you must complete all of the modules in this activity.